FDA clears Johnson & Johnson's wound dressing:
This article was originally published in Clinica
Executive Summary
Johnson & Johnson Wound Management has received US FDA 510(k) clearance for its Promogran matrix wound dressing, which it claims is the only product of its kind that combines oxidised regenerated cellulose (ORC) and collagen. The Promogran matrix is indicated for the treatment of exuding wounds including, diabetic, venous and pressure ulcers.